Related by context. All words. (Click for frequent words.) 70 Ophthalmology ARVO 70 AASLD 68 ASBMR 68 ASCRS 68 ICAAC IDSA 66 Gastrointestinal Cancers Symposium 66 nd Annual Meeting 65 ASGT 65 ECTRIMS 65 ICAAC 64 AACR NCI EORTC 64 UEGW 64 Keystone Symposia 64 Genitourinary Cancers Symposium 63 ISPOR 63 ACR ARHP 63 ECCMID 62 ASH Annual Meeting 62 Digestive Disease Week DDW 62 Biophysical Society 62 Cancers Symposium 62 Ophthalmology ARVO Annual Meeting 62 ASCO GI 62 Transcatheter Cardiovascular Therapeutics TCT 62 Clinical Oncology Annual Meeting 62 Endocrine Society Annual Meeting 62 Connective Tissue Oncology 62 BioContact Quebec 62 CIRSE 62 ESCRS 62 SABCS 61 Cambridge Healthtech Institute 61 #th Annual Interscience 61 Digestive Diseases Week 61 ASCO Annual Meeting 61 Prostate Cancer Symposium 61 Wound Healing Society 61 ASCO GU 61 AACR San Antonio 61 Therapeutics TCT 60 EASD 60 ISHLT 60 st Annual Meeting 60 EUROGIN 60 AAPM 60 EFNS 60 Digestive Disease Week 60 ARVO Annual Meeting 60 AACR #st Annual Meeting 60 Society CTOS 60 EORTC NCI AACR 60 Late Breaker 60 #nd Annual Meeting 60 CLEO QELS 60 Macular Disease 59 SAWC 59 ESMO 59 EuroPCR 59 ADA Scientific Sessions 59 ASCO Breast Cancer 59 Therapeutics TCT scientific 59 Ophthalmology AAO 59 EASL 59 AUA Annual Meeting 59 CROI 59 ASGCT 59 Cancer Immunotherapy 59 Molecular Medicine Tri 59 AAN Annual Meeting 58 Sirion Therapeutics 58 Transcatheter Cardiovascular Therapeutics 58 Gynecologic Cancer Society 58 #nd EORTC NCI 58 CTRC AACR San Antonio 58 ASHG 58 USpella 58 Clinical Virology Symposium 58 Pediatric Academic Societies PAS 58 Hematology Annual Meeting 58 entitled Synergistic 58 ISTH 58 ASM Biodefense 58 Oral Presentations 58 AACR Annual Meeting 58 SAGES 58 Biological Therapy 58 AACR 58 ATVB 58 Pharmaceutical Scientists AAPS 58 preclinical efficacy 58 Spine Arthroplasty Society 58 AACR Meeting 58 Cancer iSBTc 57 PROPEL 57 Breast Cancer Symposium 57 VEITHsymposium 57 BIOCOM Investor Conference 57 BiTE R 57 AANS 57 SCAI Annual 57 Diabetic Macular Edema DME 57 HORIZONS AMI 57 iSBTc 57 AASLD Meeting 57 Refractive Surgery ASCRS 57 ACAAI 57 Endocrine Society ENDO 57 Dr. Pingpank 57 DDW 57 BioProcess International 57 Phase Ib study 57 America HFSA 57 Osseointegration 57 ASNR 57 Cell Biology ASCB 57 ASCO 57 IASLC 57 EORTC NCI AACR Symposium 56 Revotar 56 Ocular Diseases 56 ACC.# 56 Biodesix 56 AOSSM 56 EyeGate Pharma 56 ASTRO Annual Meeting 56 Tumor Microenvironment 56 BioContact Québec 56 Biomedical Optics 56 Therapeutic Radiation 56 FOLOTYN ® 56 SPIE Photonics West 56 Hedgehog Pathway Inhibitor 56 Dr. Sosne 56 Malignant Mesothelioma 56 Hematology Meeting 56 Clinical Oncology Gastrointestinal Cancers 56 AAPS Annual Meeting 56 Annual ICAAC 56 Diabetic Retinopathy 56 Malignant Lymphoma 56 SCDM 56 Interventions SCAI 56 EORTC NCI 56 Targeted Anticancer Therapies 56 Endocrine Society #nd 56 BiOS 56 HDL Mimetic Peptide 56 Phase III psoriasis 56 annual Transcatheter Cardiovascular 56 Interventional Radiology SIR 56 Lung Transplantation 56 American Thoracic Society 56 Hsp# Inhibitor 56 Annual Transcatheter Cardiovascular 56 Endovascular Therapy 56 KRN# 56 Alzheimer Disease ICAD 56 HFSA Annual 56 Arteriosclerosis Thrombosis 56 ACNP 56 fosbretabulin 56 ECNP 56 Physiological Society 56 Macula Society 56 AIR2 Trial 56 Dermatology AAD 56 Opportunistic Infections CROI 56 NASDAQ LIPD 56 EAACI 56 Cardiovascular Therapeutics 56 ASCO Genitourinary Cancers Symposium 56 Microbiology ASM 55 vinca alkaloid 55 Angiogenesis 55 Hypertension ASH 55 LabAutomation# 55 Stem Cell Research ISSCR 55 AABB Annual Meeting 55 Hematology ASH 55 ASBMB 55 CRLX# 55 MASCC 55 HFSA 55 EACTS 55 ongoing Phase 1b 55 Charlesson 55 SAWC WHS 55 Gene Therapy ASGT 55 Dermatologic 55 Windhover Therapeutic Area 55 ABRF 55 Endocrine Society #st 55 Talabostat 55 Retina Specialists 55 Hematology ASH Annual Meeting 55 DDW ® 55 Advanced Neuroendocrine Tumors 55 ZYBRESTAT 55 EyeGate 55 Oncology ASTRO 55 ESTRO 55 ENMD # 55 Neurology Annual Meeting 55 vascular disrupting agent 55 Pfizer Ophthalmics 55 EORTC 55 Pediatric Academic Societies 55 Preclinical Study 55 ASTMH 55 AGBT 55 AAGP 55 Photocure ASA 55 Human Proteome Organization 55 GTCbio 55 HCV Protease Inhibitor 55 AHA Scientific Sessions 55 TG MV 55 LUMINATE 55 Cardiostim 55 LibiGel ® 55 Relypsa 55 Cellular Therapy 55 AACR #nd Annual Meeting 55 Carfilzomib 55 SMT C# 55 Tesetaxel 55 SfN 55 Clinical Oncology ASCO Annual 55 Ophthalmic Drugs Advisory 55 www.asco.org 55 Selective Cardiac Myosin 55 Afferent Pharmaceuticals 55 CIBMTR 55 Procyon Biopharma 55 AACR EORTC NCI 55 IMCCA 55 DAPT Study 55 YONDELIS R 55 Experimental Biology EB 55 International Myeloma Workshop 55 Clinical Dermatology 55 Interventional Cardiologists 55 AAGL 55 TRO# 55 MYTHOS trial 54 Applied Spectroscopy 54 Clinical Trial Results 54 Semafore Pharmaceuticals 54 ORAL Sync 54 Diabetic Macular Edema 54 Preclinical Data 54 II Clinical Trial 54 Breast Surgeons 54 ENDEAVOR IV 54 NASDAQ CXSP announced 54 EVEREST II 54 Heart Failure Society 54 Genome Biology 54 ISSWSH 54 VEITHsymposium ™ 54 ASN Renal Week 54 Oligonucleotide Therapeutics Society 54 DF HCC 54 CALGB 54 Flexivue 54 Pervasis 54 Fifth Decennial International 54 Liver Meeting 54 Antibody Therapeutics 54 Female Urology 54 Opexa 54 #st Annual Meeting 54 & Immunology AAAAI 54 diabetic macular edema DME 54 IMiDs ® compound 54 EFORT 54 Endoscopic Surgeons SAGES 54 Annual Scientific Sessions 54 Neuro Oncology SNO 54 www.internationalstemcell.com 54 Acute Heart Failure 54 Symposium SABCS 54 Respiratory Viral Infections 54 EchoCRT 54 REGiMMUNE 54 LD Micro 54 Gastroenterology ACG 54 Elagolix 54 Breaking Clinical Trials 54 pan HDAC inhibitor 54 invivodata 54 rALLy clinical trial 54 MacuSight 54 IL# PE#QQR 54 Neurology AAN 54 Cardiology ESC Congress 54 Research IADR 54 Medical Oncology ESMO 54 Wilmer Eye Institute 54 Diasome 54 Chemotherapy ICAAC 54 Podium Presentation 54 Announces Poster Presentations 54 CALGB # [002] 54 Chicago Multidisciplinary Symposium 54 Denufosol 54 Phase III Clinical Trial 54 Memgen 54 Photodynamic Therapy 54 Phase Ib clinical 54 Freedom Meditech 54 Zenvia Phase III 54 ImQuest 54 Regado Biosciences 54 PEG SN# 54 Genocea Biosciences 54 Microplasmin 54 resolvin 54 #th Interscience Conference 54 Dr. Yatscoff 54 GammaCan 54 ESBATech 54 Ocular Pharmacology 54 Naurex 54 SPIRIT IV 54 PsychoGenics 54 Prof. Gozes 54 EADV 54 ® DDW 54 BIO InvestorForum 53 OTCBB AOLS 53 abstracts summarizing 53 ENDO 53 MT# MEDI 53 Logical Therapeutics 53 EXPAREL ™ 53 Canaccord Adams Hepatitis C 53 Vulnerable Plaque 53 Romidepsin 53 immatics 53 Curon Medical 53 NIBIB 53 NASDAQ SLXP today 53 League Against Rheumatism 53 Manja Bouman CEO 53 GASTRO 53 Addex Pharmaceuticals SWISS ADXN 53 INSPIRE Trial Phase III 53 www.rxipharma.com 53 Cell Transplant 53 SIIM 53 Medicine SIIM 53 Innate Immunity 53 Pediatric Diabetes 53 Trandolapril 53 IADR 53 ACR ARHP Annual 53 BioPharm America 53 Nasdaq ENZN 53 Poster Presentations 53 Investigative Pathology 53 Refractory Angina 53 Sym# 53 ISMB 53 Molecular Targets 53 Iluvien ® 53 OHR/AVR# 53 Squalamine 53 Systemic Sclerosis 53 Daniel Von Hoff 53 Urocortin 2 53 Antiviral Research 53 Pediatric Academic Society 53 BioNumerik 53 ISPE 53 Clinical Chemistry AACC 53 NASDAQ PCYC 53 ASNC 53 Molecular Pathology AMP 53 BioContact 53 YONDELIS 53 Anticancer Drug 53 non nucleoside inhibitor 53 NSTI Nanotech 53 Therapeutic Targets 53 programs visit http:/www.bionovo.com 53 trastuzumab DM1 T DM1 53 Hematology ASH Meeting 53 Oncologic 53 Amarantus 53 ERA EDTA 53 Aflibercept 53 Mineral Research ASBMR 53 Sirion Therapeutics Inc. 53 CorMatrix 53 Dr. Siegall 53 European CanCer Organisation 53 Avila Therapeutics 53 Nasdaq GNTA 53 NASDAQ CYTK announced 53 Othera Pharmaceuticals Inc. 53 histone deacetylase HDAC inhibitor 53 Chemokine Therapeutics 53 Canaccord Adams Musculoskeletal 53 Rheumatology ACR Annual 53 verteporfin 53 Controlled Release 53 NCCTG 53 IMPROVE HF 53 Urodynamics 53 phase IIb clinical 53 Phase 2b Clinical Trial 53 Blinatumomab 53 IMiDs R 53 Imedex 53 Lysosomal Disease Network 53 Phase III ALLEGRO 53 OZURDEX ® 53 cyclophilin inhibitors 53 Poster Discussion 53 Endovascular Therapy ISET 53 Semafore 53 LabAutomation 53 Nasdaq IDRA today 53 delafloxacin 53 ToGA 53 Bipolar Disorders 53 Inflammatory Arthritis 53 Phase Ib Clinical Trial 53 HUPO 53 Syndax 52 Sunovion 52 Tanespimycin 52 American Roentgen Ray 52 AAAAI 52 th Annual Interscience 52 Liver EASL 52 AACR symposium 52 Breaking Clinical Trial 52 Phase 1b trial 52 PAINWeek 52 Vaccine Adjuvant 52 Reata Pharmaceuticals 52 Nasdaq IMGN 52 Long Awaited Reality 52 Atrial Fibrillation Symposium 52 IRX Therapeutics 52 Nasdaq ALXN 52 Cancer Therapeutic 52 ISTA Pharmaceuticals 52 OCuSOFT 52 ThermoDox ® clinical 52 Enanta 52 Inc. Nasdaq AVRX 52 Delcath Phase III 52 HCV NS5B polymerase 52 American Urological Association 52 PHT Corporation 52 Edge STudy 52 Unither 52 Vascular Biology ATVB 52 Guanilib 52 phase IIa clinical 52 AREDS 52 Outcome Sciences 52 Bioheart Inc. 52 Breast Cancer Symposium SABCS 52 AcuFocus 52 www.ucb group.com 52 ASCB 52 JAK2 Inhibitor 52 M.D. Ph.D. 52 Dr. Sidransky 52 Kibow Biotech 52 Biodefense Vaccines 52 EULAR 52 ECCO ESMO 52 ELSO 52 Pharmacoeconomics 52 Omacetaxine 52 Diaton 52 ALTROPANE 52 Biotech Showcase 52 Clinical Oncologists 52 abstracts 52 Dr. Gussak 52 Respiratory Society 52 Translational Regenerative Medicine 52 Cardiovascular Angiography 52 Pivotal Trial 52 Oral Presentation 52 Neuraltus 52 recurrent glioma 52 Raymedica 52 retinal vein occlusion RVO 52 Human Genetics ASHG 52 Bascom Palmer Eye 52 Nephrology Renal Week 52 number NCT# ClinicalTrials.gov 52 ABI OTCBB AMAR 52 Protein Therapeutics 52 huC# DM4 52 multicenter Phase II 52 ONTARGET 52 forodesine 52 HQK 52 LHON 52 Pathology Visions 52 Retinal Degeneration 52 R roscovitine 52 Prospective Randomized 52 EULAR Annual 52 Pharmatech Oncology 52 Lab Automation 52 Inflammatory Bowel Diseases 52 ERYtech 52 Gynecologic Oncologists SGO 52 Electro Optics Society 52 unoprostone isopropyl 52 Select Biosciences 52 Cellular Therapy ISCT 52 Mechanical Circulatory Support 52 http:/www.vivus.com 52 vismodegib 52 Cardiology ESC 52 Kinase Inhibitor 52 Gastrointestinal Oncology 52 Nereus Pharmaceuticals 52 CTRC AACR 52 iBIO Institute 52 Noscira 52 Epiphany Biosciences 52 ZYBRESTAT TM 52 www.pranabio.com 52 PSN# [002] 52 SUCCEED trial 52 Urology EAU 52 Dr. Dov Tamarkin 52 Endovascular Valve Edge 52 Ph.D. MD hc 52 Cancer Therapeutics 52 SAEM Annual Meeting 52 International OARSI 52 Gynecologic Investigation 52 Epilepsy Society 52 pralatrexate injection folate analogue 52 NABTT 52 interventional cardiovascular 52 Catena ® 52 ISSCR 52 LUMEN 52 Tarvacin TM 52 Phase Ib II 52 RNA interference RNAi therapeutics 52 Personalized Immunotherapy 52 ASA CSSA SSSA 52 ICCAD 52 Double Blind Placebo 52 ON #.Na 52 multicenter prospective 52 acetonide FA 52 preclinical pharmacokinetic 52 Ovarian PLCO Cancer 52 ProLindac TM 52 Dr. Gulfo 52 Immunology AAAAI 52 Cardiovascular Anesthesiologists 52 FNIH 52 ROCKET AF 52 Ophthalmology Annual Meeting 52 Dr. Grekos 52 Haemostasis ISTH 52 NASDAQ ARRY 52 brivaracetam 52 Gynecologic Oncologists 51 prospective multicentre 51 Initiates Clinical Trial 51 Medicine ISMRM 51 Novel Approaches 51 Cerimon 51 Dr. Blobel 51 SiDMAP 51 Angelman Syndrome Foundation 51 Traficet EN 51 Preclinical Development 51 darinaparsin ZIO 51 LEUKINE 51 prospective multicenter 51 lipidomics 51 Preclinical Efficacy 51 NCVH 51 Outcomes Research ISPOR 51 CED Biotech 51 Genta Incorporated OTCBB GETA 51 Antimicrobial Agents 51 FluoroPharma 51 Deforolimus 51 UCLA California NanoSystems 51 visit www.lupus.org 51 BARI 2D 51 Phase #b/#a clinical 51 COPIC Energy 51 GITA Annual 51 Neurological Surgeons AANS 51 Ozurdex 51 Neck Cancer 51 novel histone deacetylase 51 uveitis 51 Phase 1a clinical 51 Recurrent Chest Wall 51 FDA Oncologic Drugs 51 genitourinary cancers 51 Hedgehog antagonist 51 Windhover Information 51 Phase 2a clinical 51 PRNewswire FirstCall Genaera 51 Zarnestra 51 ACerS 51 Vascugel 51 Durata Therapeutics 51 Autoimmunity 51 European CanCer Organisation ECCO 51 ThinkEquity Partners Growth 51 HDAC Inhibitor 51 AIDS Vaccine 51 Aplidin 51 enzastaurin 51 prospective multicenter study 51 SEMDA 51 RhuDex 51 photodisinfection 51 WE MOVE 51 kidney urologic 51 BCIRG 51 AIBS 51 pharmacokinetic PK study 51 Cytori NASDAQ CYTX 51 CEQ# 51 OLYMPIA registry 51 vidofludimus 51 Presents Preclinical Data 51 MOZOBIL 51 Artelon ® 51 Aryplase 51 Phase III ADT 51 AA Amyloidosis 51 CombAT 51 QLT# 51 Human Brain Mapping 51 ARRY # 51 Idenix Pharmaceuticals 51 PFO migraine 51 Autoimmune Diseases 51 Presents Positive 51 Fresenius Biotech 51 Chronix 51 BioMarck 51 phase IIIb 51 GW# [003] 51 Perceptronix 51 targeting CD# 51 Elan NanoCrystal 51 Gynecological Cancer 51 PNT# 51 Business Analysis IIBA 51 Canaccord Genuity Growth 51 Agendia BV 51 seliciclib CYC# 51 MelaFind R 51 Inc. Nasdaq IMGN 51 ALN HTT 51 Acute Ischemic Stroke 51 Diabetes EASD 51 enGene 51 SIR Spheres 51 Pirfenidone 51 transthyretin TTR mediated amyloidosis 51 HuMax EGFr 51 Clinical Efficacy 51 Nasdaq SGMO announced 51 CR# vcMMAE 51 Combination REOLYSIN R 51 Phase IIB 51 Bone Marrow Transplantation 51 CA4P 51 Addex Pharmaceuticals Ltd. 51 BRIM3 51 Antiviral Activity 51 gastrointestinal stromal tumors GIST 51 International Papillomavirus 51 Mass Spectrometry ASMS 51 Scrip Awards 51 Cachexia 51 depsipeptide 51 Nasdaq SNSS 51 FDLI 51 EGS# 51 J.P. Morgan Healthcare 51 www.aacr.org 51 randomized Phase III 51 BioCentury Future Leaders 51 Clinical Trial Data 51 retinal specialists 51 Phase #/#a 51 Phase 2a Study 51 radezolid 51 Phase 2b Trial 51 Aegis Therapeutics 51 PDE# inhibitors 51 orally inhaled migraine 51 Presents Preclinical 51 Safinamide 51 Neural Repair 51 In3 EUROPE 51 phase IIb study 51 Cardiovascular Horizons 51 Dr. Ruoslahti 51 RGB # 51 Solorel TM 51 Tetraphase 51 Gastrointestinal Cancer 51 Immunologists 51 JAK1 51 lorcaserin Phase 51 sunitinib malate 51 angiogenesis inhibitor 51 Interscience Conference 51 CLARITY study 51 Echocardiography ASE 51 Refractive Surgeons 51 Aplidin R 51 midstage clinical 51 Nephrology ASN 51 Otonomy 51 REALITY Trial 51 Scientific Sessions 51 ASSERT 51 Biosyntrx 51 CRVO 51 Capsule Endoscopy 51 PEGylated interferon beta 1a 51 Fabry Disease 51 PRNewswire FirstCall Pressure BioSciences 51 Nasdaq CYCC Nasdaq CYCCP 51 GTCbio 3rd 51 Extina 51 IDRI 51 Hydra Biosciences 51 Photocure 51 Preclinical Studies 51 REG2 51 RNAi Therapeutics 51 Scientific Session 51 ganetespib 51 Therapeutix 51 ISTA Pharmaceuticals Inc. 51 Simulect 51 BIOMED 51 Minimally Invasive Cardiothoracic Surgery 51 Quinamed 51 RADIANT 51 Hematological Malignancies 51 Wonca 51 Xcytrin R 51 SoftScan R 51 NCIC CTG 51 Movement Disorder 51 See CLINICAL PHARMACOLOGY 51 Lennart Nilsson Award 51 Aggressive Reduction 51 Cascade LifeSciences 51 FOCIS 51 neratinib 51 Hyphanox 51 Immunotherapeutic 51 J. Mazzo Ph.D. 50 Diabetic Foot 50 PROactive Study 50 AviaraDx 50 Sansum Diabetes Research 50 Distinguished Scientist Award 50 Nasdaq MBRX announced 50 Interstitial Cystitis 50 Pacific Biometrics 50 Adult Stem Cell Therapy 50 BIO VentureForum East 50 GVAX ® 50 Wound Ostomy 50 Intraoperative Surgical Planning 50 C# BioVentures 50 NASDAQ IDRA 50 TRA 2P 50 Kahalalide F 50 Radiation Oncology ASTRO 50 QuatRx 50 RCW Breast Cancer 50 InSite Vision 50 Oral Fingolimod 50 Cutaneous T 50 AAO HNS 50 Surgery ASLMS 50 CRMD# 50 KYTHERA 50 Imaging Informatics 50 Abstract Accepted 50 DermTech International 50 Proc Am Soc 50 Dr. Ayalew Tefferi 50 Clinicaltrials.gov 50 ISPD 50 NSABP 50 EXPAREL TM 50 Antibody Engineering 50 Amorcyte 50 Prostate Disease 50 ORIDIS Biomed 50 PSORIASIS 50 MedNet Solutions 50 ISMPP 50 Hana Biosciences 50 Rheumatology Annual 50 AAO HNSF Annual Meeting 50 oral prodrug 50 Histocompatibility 50 Thomas Ichim 50 Yondelis ® 50 PhotoPoint R 50 Zybrestat 50 journal Optometry 50 First Patient Enrolled 50 Trophos 50 OMP #M# 50 DIA Annual Meeting 50 Regulus Therapeutics 50 Oramed 50 multicenter phase 50 CytoDyn Inc. 50 CCX# 50 TMC# C# 50 Calistoga Pharmaceuticals 50 Symadex 50 Samaritan Pharmaceuticals 50 lens IOL 50 www.snwusa.com 50 NIH Consensus 50 MEK inhibitor 50 tasocitinib 50 Systemic Delivery 50 phase IIb trial 50 ThermoDox R 50 AMCP 50 SPIRIT FIRST 50 ZYBRESTAT fosbretabulin 50 ALN VSP 50 Addex Pharmaceuticals SIX ADXN 50 PROSTVAC TM 50 plerixafor 50 Vitreoretinal 50 Phase 1b clinical trials 50 E CENP E 50 STENT 50 miRagen 50 HORIZONS AMI trial 50 ESHRE 50 Selective Cardiac Myosin Activator 50 HIMSS# Interoperability Showcase 50 multicenter trials 50 RAPAFLO R 50 Angiolix 50 HepaSphere 50 BIO# 50 Intervention Trial GAIT 50 Visiogen 50 Bazedoxifene 50 diabetic macular edema 50 Eluting Coronary Stent System 50 AAEP Convention 50 ILUVIEN ® 50 Neoplasia 50 Radiation Oncologists 50 Belimumab 50 Neuropsychopharmacology ACNP 50 Nasdaq CLSN 50 evaluating tivozanib 50 CYT# potent vascular disrupting 50 Halozyme Therapeutics 50 PhotoCure 50 OneMedForum 50 RE LY trial 50 Nasdaq PCYC 50 Neurotology 50 Lumbar Spine 50 Elisabeth Lindner CEO 50 SUTENT ® 50 FDA Approvable Letter 50 Retroviruses 50 Biophysical Society Annual Meeting 50 Pivotal Clinical Trial 50 WLSA Convergence Summit 50 Deutsches Herzzentrum 50 & OTO EXPO 50 NanoBioTechnology 50 UCB Pharma 50 Annual HIMSS 50 unSUMMIT 50 Bifantis 50 liposome injection 50 RE LY 50 ASMBS 50 RTOG 50 Electro Optics CLEO 50 AAICAD 50 Autoimmune Disease 50 Midyear Clinical Meeting 50 Onconova Therapeutics Inc. 50 atypical Hemolytic Uremic Syndrome 50 Patient Registry 50 Omthera 50 ACOMPLIA R 50 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 50 biodegradable implant 50 Aganocide 50 Corp. NASDAQ PSDV 50 IMCAS 50 novel peptides 50 Source MDx 50 huN# DM1 50 Biologic Therapy 50 Islet Transplantation 50 Annual Meeting 50 Clinuvel 50 TAXUS ATLAS 50 Pervasis Therapeutics 50 Daclizumab 50 FDA Advisory Panel 50 Acute Decompensated Heart Failure 50 Neotropix 50 MLN# 50 HCV polymerase inhibitors 50 Craig Hallum Institutional Investor 50 ASCO abstract 50 AIMBE 50 Dry Eye 50 KAMRA inlay 50 GLOBE NEWSWIRE Pressure BioSciences 50 Vascular Disease 50 eyeforpharma 50 oral FTY# 50 perifosine KRX 50 prostate cancer mCRPC 50 SU# [003] 50 histone deacetylase inhibitor 50 eltrombopag 50 EGEN 50 SupplySide East 50 NFID 50 Biotherapy 50 DMD DMSc 50 Neuro Oncology 50 DFCI 50 Sidney Kimmel Cancer 50 Multicenter 50 Vascular Disease Foundation 50 HDAC Inhibitors 50 NYSE Alternext ULU 50 Exco InTouch 50 OXi# 50 phase IIa 50 vascular disrupting agents 50 ADVANCE PD 50 Mid Atlantic Bio 50 PROSTASCINT R 50 AIUM 50 ALS MND 50 Scientific Meeting 50 Daniel Junius 50 Reports Preclinical Data 50 JAK2 inhibitor 50 OMNARIS Nasal Spray 50 HIMSS Healthcare 50 Immune Tolerance Network 50 Metastatic Melanoma 50 AAAAI Annual Meeting 50 Rheumatologists 50 Central Retinal Vein 50 Liprostin 50 BiTE antibody MT# 50 Marrow Transplant Research 50 Indaflex TM 50 Genous stent 50 SCCE 50 San Antonio Breast Cancer 50 Metabolic Disease 50 cardio renal 50 CHEST 50 AACR NCI EORTC Molecular 50 ORMD 50 UTSW 50 TARIS